FDA Approves Leqembi for Alzheimer’s TreatmentJuly 9, 2023 News The U.S. Food and Drug Administration (FDA) has granted full approval to Leqembi, an Alzheimer’s drug developed by Japanese pharmaceutical…
Challenges for Biogen’s Alzheimer’s Drug ApprovalJuly 7, 2023 News Biogen Inc. shares failed to rally despite a milestone drug approval by the U.S. Food and Drug Administration (FDA) for…
